It indicated a better prognosis for PFS (P = 1.862e-03), DSS (P = 4.566e-03), and OS (P = 5.864e-03) in UCEC cases (Fig. 3C) with altered PRKDC, and better prognosis for PFS (P = 1.582e-03) and DSS (P = .0366) in STAD cases (Fig. 3D) with altered PRKDC, compared with cases without PRKDC alteration. Here, PRKDC is linked to gastric adenocarcinoma.